4//SEC Filing
HERSHBERG ROBERT 4
Accession 0001193125-25-206257
CIK 0001888012other
Filed
Sep 16, 8:00 PM ET
Accepted
Sep 17, 4:30 PM ET
Size
5.5 KB
Accession
0001193125-25-206257
Insider Transaction Report
Form 4
HilleVax, Inc.HLVX
HERSHBERG ROBERT
DirectorSee Remarks
Transactions
- Disposition from Tender
Common Stock
2025-09-17−1,101,498→ 0 total
Footnotes (1)
- [F1]In connection with that certain Agreement and Plan of Merger, dated as of August 4, 2025 (the "Merger Agreement"), by and among the Issuer, XOMA Royalty Corporation ("Parent") and XRA 4 Corp., a wholly owned subsidiary of Parent ("Merger Sub" and together with Parent, the "Purchasers"), the Purchasers completed a tender offer to acquire all of the issued and outstanding shares of Common Stock of the Issuer in exchange for (a) $1.95 in cash per share (the "Cash Amount"), plus (b) one contingent value right ("CVR") representing the right to receive certain contingent cash payments equal to the "CVR Proceeds" as further described in that certain CVR Agreement entered into between the Purchasers and a representative to the CVR holders. After completion of the tender offer, Merger Sub merged with and into the Issuer, effective as of September 17, 2025 (the "Effective Time"), with the Issuer continuing as the surviving corporation and as a wholly owned subsidiary of Parent.
Documents
Issuer
HilleVax, Inc.
CIK 0001888012
Entity typeother
Related Parties
1- filerCIK 0001274139
Filing Metadata
- Form type
- 4
- Filed
- Sep 16, 8:00 PM ET
- Accepted
- Sep 17, 4:30 PM ET
- Size
- 5.5 KB